|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
|
China Medicine Corporation
|
|
(Name of Issuer)
|
|
|
|
|
|
Common Stock, par value $0.0001 per share
|
|
(Title of Class of Securities)
|
|
|
|
|
|
000-51379
|
|
(CUSIP Number)
|
|
|
|
|
OEP CHME Holdings, LLC
|
OEP CHME Holdings, LLC
|
|
|
|
c/o One Equity Partners
|
c/o One Equity Partners
|
|
|
|
Chater House, 20F
|
320 Park Avenue, 18
th
Floor
|
|
|
|
8 Connaught Road Central
|
New York, NY 10022
|
New York, NY 10022
|
|
|
Hong Kong
|
212-277-1500
|
|
|
|
+852 2167 8517
|
Attention: Richard W. Smith
|
|
|
|
Attention: Ryan Shih
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
|
|
|
|
|
|
September 17, 2012
|
|
(Date of Event Which Requires Filing of this Statement)
|
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
Note
: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. ___000-51379_________________
|
1.
|
Names of Reporting Persons.
|
|
|
|
|
|
OEP CHME Holdings, LLC
|
|
|
I.R.S. Identification Nos. of above persons (entities only).
|
|
|
27-1672808
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a) [ ]
|
|
|
(b) [ x ]
|
|
4.
|
Source of Funds (See Instructions)
|
|
|
|
|
|
|
|
|
OO
|
|
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ]
|
|
|
|
|
|
|
|
6.
|
Citizenship or Place of Organization
|
|
|
|
|
|
Delaware
|
|
Number of
|
7. Sole Voting Power
|
|
Shares Bene-
|
0
|
|
ficially
|
8. Shared Voting Power
|
|
Owned by Each
|
18,472,560*
|
|
Reporting
|
9. Sole Dispositive Power
|
|
Person With:
|
0
|
|
|
10. Shared Dispositive Power
|
|
|
11,892,560**
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
|
11,892,560**
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ x ]
|
|
|
|
|
|
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
|
|
|
|
|
|
42.7%***
|
|
14.
|
Type of Reporting Person (See Instructions)
|
|
|
|
|
|
OO (Limited Liability Company)
|
|
*
|
Pursuant to Rule 13-d-4 under the Exchange Act, the Reporting Persons disclaim beneficial ownership of an aggregate amount of 6,580,000 shares of Common Stock that are beneficially owned by Mr. Yang, Ms. Liu and Mr. Liu, as described in Item 5 (the “
Disclaimed Shares
”), for all purposes except as to shared voting power to the extent set forth in Section 3.1 of the Shareholders Agreement, as described in Item 6, and this report shall not be deemed an admission that the Reporting Persons beneficially own the Disclaimed Shares. Furthermore, to the extent that, as described in Item 5, the Reporting Persons and Mr. Yang, Ms. Liu and Mr. Liu may be deemed to constitute a “group” within the meaning of Rule 13d-5(b) under the Exchange Act, the Reporting Persons expressly disclaim membership in such group except to the extent of such shared voting power.
|
|
|
|
|
**
|
Consists of (a) 8,333,334 shares of Common Stock plus (b) 355,922.6 shares of Redeemable Convertible Preferred Stock, which are convertible into 3,559,226 shares of Common Stock. The calculation of the number of shares of Common Stock that the shares of Preferred Stock are convertible into is based on the conversion price as of September 17, 2012.
|
|
|
|
|
***
|
For the purpose of Rule 13d-3 under the Securities Exchange Act, we have assumed that all shares of Common Stock into which the shares of Preferred Stock are convertible are currently issued and outstanding. The foregoing percentage is calculated based on 27,837,970 shares of Common Stock of the Issuer outstanding on a fully-diluted basis as of September 17, 2012, which includes the Preferred Stock beneficially owned by the Reporting Persons.
|
CUSIP No. ____000-51379________________
|
1.
|
Names of Reporting Persons.
|
|
|
|
|
|
One Equity Partners III, L.P.
|
|
|
I.R.S. Identification Nos. of above persons (entities only).
|
|
|
98-0564090
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a) [ ]
|
|
|
(b) [ x ]
|
|
4.
|
Source of Funds (See Instructions)
|
|
|
|
|
|
|
|
|
OO
|
|
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ]
|
|
|
|
|
|
|
|
6.
|
Citizenship or Place of Organization
|
|
|
|
|
|
Cayman Islands
|
|
Number of
|
7. Sole Voting Power
|
|
Shares Bene-
|
0
|
|
ficially
|
8. Shared Voting Power
|
|
Owned by Each
|
18,472,560*
|
|
Reporting
|
9. Sole Dispositive Power
|
|
Person With:
|
0
|
|
|
10. Shared Dispositive Power
|
|
|
11,892,560**
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
|
11,892,560**
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ x ]
|
|
|
|
|
|
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
|
|
|
|
|
|
42.7%***
|
|
14.
|
Type of Reporting Person (See Instructions)
|
|
|
|
|
|
PN
|
|
*
|
Pursuant to Rule 13-d-4 under the Exchange Act, the Reporting Persons disclaim beneficial ownership of an aggregate amount of 6,580,000 shares of Common Stock that are beneficially owned by Mr. Yang, Ms. Liu and Mr. Liu, as described in Item 5 (the “
Disclaimed Shares
”), for all purposes except as to shared voting power to the extent set forth in Section 3.1 of the Shareholders Agreement, as described in Item 6, and this report shall not be deemed an admission that the Reporting Persons beneficially own the Disclaimed Shares. Furthermore, to the extent that, as described in Item 5, the Reporting Persons and Mr. Yang, Ms. Liu and Mr. Liu may be deemed to constitute a “group” within the meaning of Rule 13d-5(b) under the Exchange Act, the Reporting Persons expressly disclaim membership in such group except to the extent of such shared voting power.
|
|
|
|
|
**
|
Consists of (a) 8,333,334 shares of Common Stock plus (b) 355,922.6 shares of Redeemable Convertible Preferred Stock, which are convertible into 3,559,226 shares of Common Stock. The calculation of the number of shares of Common Stock that the shares of Preferred Stock are convertible into is based on the conversion price as of September 17, 2012.
|
|
|
|
|
***
|
For the purpose of Rule 13d-3 under the Securities Exchange Act, we have assumed that all shares of Common Stock into which the shares of Preferred Stock are convertible are currently issued and outstanding. The foregoing percentage is calculated based on 27,837,970 shares of Common Stock of the Issuer outstanding on a fully-diluted basis as of September 17, 2012, which includes the Preferred Stock beneficially owned by the Reporting Persons.
|
CUSIP No. ____000-51379________________
|
1.
|
Names of Reporting Persons.
|
|
|
|
|
|
OEP General Partner III, L.P.
|
|
|
I.R.S. Identification Nos. of above persons (entities only).
|
|
|
98-0563874
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a) [ ]
|
|
|
(b) [ x ]
|
|
4.
|
Source of Funds (See Instructions)
|
|
|
|
|
|
|
|
|
OO
|
|
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ]
|
|
|
|
|
|
|
|
6.
|
Citizenship or Place of Organization
|
|
|
|
|
|
Cayman Islands
|
|
Number of
|
7. Sole Voting Power
|
|
Shares Bene-
|
0
|
|
ficially
|
8. Shared Voting Power
|
|
Owned by Each
|
18,472,560*
|
|
Reporting
|
9. Sole Dispositive Power
|
|
Person With:
|
0
|
|
|
10. Shared Dispositive Power
|
|
|
11,892,560**
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
|
11,892,560**
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ x ]
|
|
|
|
|
|
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
|
|
|
|
|
|
42.7%***
|
|
14.
|
Type of Reporting Person (See Instructions)
|
|
|
|
|
|
PN
|
|
*
|
Pursuant to Rule 13-d-4 under the Exchange Act, the Reporting Persons disclaim beneficial ownership of an aggregate amount of 6,580,000 shares of Common Stock that are beneficially owned by Mr. Yang, Ms. Liu and Mr. Liu, as described in Item 5 (the “
Disclaimed Shares
”), for all purposes except as to shared voting power to the extent set forth in Section 3.1 of the Shareholders Agreement, as described in Item 6, and this report shall not be deemed an admission that the Reporting Persons beneficially own the Disclaimed Shares. Furthermore, to the extent that, as described in Item 5, the Reporting Persons and Mr. Yang, Ms. Liu and Mr. Liu may be deemed to constitute a “group” within the meaning of Rule 13d-5(b) under the Exchange Act, the Reporting Persons expressly disclaim membership in such group except to the extent of such shared voting power.
|
|
|
|
|
**
|
Consists of (a) 8,333,334 shares of Common Stock plus (b) 355,922.6 shares of Redeemable Convertible Preferred Stock, which are convertible into 3,559,226 shares of Common Stock. The calculation of the number of shares of Common Stock that the shares of Preferred Stock are convertible into is based on the conversion price as of September 17, 2012.
|
|
|
|
|
***
|
For the purpose of Rule 13d-3 under the Securities Exchange Act, we have assumed that all shares of Common Stock into which the shares of Preferred Stock are convertible are currently issued and outstanding. The foregoing percentage is calculated based on 27,837,970 shares of Common Stock of the Issuer outstanding on a fully-diluted basis as of September 17, 2012, which includes the Preferred Stock beneficially owned by the Reporting Persons.
|
CUSIP No. _____000-51379_______________
|
1.
|
Names of Reporting Persons.
|
|
|
|
|
|
OEP Parent LLC
|
|
|
I.R.S. Identification Nos. of above persons (entities only).
|
|
|
27-3449378
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a) [ ]
|
|
|
(b) [ x ]
|
|
4.
|
Source of Funds (See Instructions)
|
|
|
|
|
|
|
|
|
OO
|
|
|
|
|
5.
|
Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ]
|
|
|
|
|
|
|
|
6.
|
Citizenship or Place of Organization
|
|
|
|
|
|
Delaware
|
|
Number of
|
7. Sole Voting Power
|
|
Shares Bene-
|
0
|
|
ficially
|
8. Shared Voting Power
|
|
Owned by Each
|
18,472,560*
|
|
Reporting
|
9. Sole Dispositive Power
|
|
Person With:
|
0
|
|
|
10. Shared Dispositive Power
|
|
|
11,892,560**
|
|
11.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
|
11,892,560**
|
|
12.
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [x ]
|
|
|
|
|
|
|
|
13.
|
Percent of Class Represented by Amount in Row (11)
|
|
|
|
|
|
42.7%***
|
|
14.
|
Type of Reporting Person (See Instructions)
|
|
|
|
|
|
HC; CO
|
|
*
|
Pursuant to Rule 13-d-4 under the Exchange Act, the Reporting Persons disclaim beneficial ownership of an aggregate amount of 6,580,000 shares of Common Stock that are beneficially owned by Mr. Yang, Ms. Liu and Mr. Liu, as described in Item 5 (the “
Disclaimed Shares
”), for all purposes except as to shared voting power to the extent set forth in Section 3.1 of the Shareholders Agreement, as described in Item 6, and this report shall not be deemed an admission that the Reporting Persons beneficially own the Disclaimed Shares. Furthermore, to the extent that, as described in Item 5, the Reporting Persons and Mr. Yang, Ms. Liu and Mr. Liu may be deemed to constitute a “group” within the meaning of Rule 13d-5(b) under the Exchange Act, the Reporting Persons expressly disclaim membership in such group except to the extent of such shared voting power.
|
|
|
|
|
**
|
Consists of (a) 8,333,334 shares of Common Stock plus (b) 355,922.6 shares of Redeemable Convertible Preferred Stock, which are convertible into 3,559,226 shares of Common Stock. The calculation of the number of shares of Common Stock that the shares of Preferred Stock are convertible into is based on the conversion price as of September 17, 2012.
|
|
|
|
|
***
|
For the purpose of Rule 13d-3 under the Securities Exchange Act, we have assumed that all shares of Common Stock into which the shares of Preferred Stock are convertible are currently issued and outstanding. The foregoing percentage is calculated based on 27,837,970 shares of Common Stock of the Issuer outstanding on a fully-diluted basis as of September 17, 2012, which includes the Preferred Stock beneficially owned by the Reporting Persons.
|
This Amendment No. 3 amends the Schedule 13D (the “
Schedule 13D
”) filed with the Securities and Exchange Commission (the “
Commission
”) on February 1, 2010, as amended by Amendment No. 1 filed with the Commission on March 5, 2010, and as further amended by Amendment No. 2 filed with the Commission on November 10, 2010 by OEP CHME Holdings, LLC (“
OEP
”), One Equity Partners III, L.P., OEP General Partner III, L.P., OEP Parent Corporation and OEP Holding Corporation (One Equity Partners III, L.P., OEP General Partner III, L.P., and OEP Parent LLC collectively, with OEP, the “
Reporting Persons
”), with respect to common stock, $0.0001 par value per share (the “
Common Stock
”), of China Medicine Corporation, a Nevada corporation (the “
Issuer
”). Capitalized terms used, but not defined herein, have the meanings ascribed to them in the Schedule 13D, as amended by Amendment No. 1, and as further amended by Amendment No. 2.
Item 1. Security and Issuer
Item 2. Identity and Background
The name, residence or business address, and present principal occupation or employment of each director, executive officer and controlling person of the Reporting Persons are listed on Schedule A to this Amendment No. 3.
During the past five years, none of the Reporting Persons nor, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A to this Amendment No. 3 (i) has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
The consideration used by the Issuer for the redemption of Preferred Stock was disbursed from the Escrow Account (as defined in the description of the Escrow Agreement in Item 6 hereto).
Item 4. Purpose of Transaction
Item 4 is hereby amended and supplemented as follows:
Except as set forth in this Item 4, none of the Reporting Persons, nor to the knowledge of each Reporting Person, any individuals listed in response to Item 2 of Schedule 13D, has any current plans or proposals that relate to or that would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of Schedule 13D.
Section 4.11 of the Stock Subscription Agreement between OEP, the Issuer and Mr. Senshan Yang, dated December 31, 2009 (the “
Stock Subscription Agreement
”) and Section 4 of the Certificate of Designation, Rights and Preferences, Redeemable Convertible Preferred Stock, China Medicine Corporation, dated as of December 31, 2009 (the “
Certificate of Designation
”) grant OEP the right to redeem Preferred Stock using funds held in the Escrow Account.
Pursuant to section 4.11 of the Stock Subscription Agreement, the number of shares to be redeemed, together with the value of each such share, is to be determined according to the formula set out therein.
Consequently, on September 17, 2012, OEP redeemed a total of 1,130,744 shares of Preferred Stock for the total consideration of Renminbi 240,607,814.14, at $33.3982862 per share.
For the avoidance of doubt, the disbursement of funds from the Escrow Account shall not constitute a disbursement of Escrow Funds (as defined in the Certificate of Designation) to the Issuer triggering an Automatic Conversion Event (as defined in the Certificate of Designation) under Section 6(b) of the Certificate of Designation, and shall not result in the conversion of Preferred Stock into Common Stock.
In addition, with respect to the Loan made by OEP to the Issuer that has not been repaid as of September 17, 2012, OEP intends to redeem that number of shares of Preferred Stock redeemable in accordance with the formula set forth in Section 4.11 of the Stock Subscription Agreement and Section 4 of the Certificate of Designation upon repayment of the Loan by the Issuer.
Furthermore, pursuant to Section 4.11 of the Stock Subscription Agreement, Section 11 of the Guangzhou Escrow Agreement and Section 4 of the Certificate of Designation, OEP intends to redeem that number of shares of Preferred Stock redeemable from the
Guangzhou Escrow Account in accordance with the formula set forth in Section 4.11 of the Stock Subscription Agreement and Section 4 of the Certificate of Designation on a date to be determined by OEP.
Item 5. Interest in Securities of the Issuer
Item 5 is hereby amended and supplemented by adding the following:
Immediately before the redemption as described in Item 4, OEP and each of the other Reporting Persons may have been deemed to own beneficially 23,200,000 shares of Common Stock, which included 8,333,333 shares of Common Stock and 14,866,667 shares of Common Stock issuable upon the conversion of 1,486,666.7 Preferred Shares, representing approximately 59.3% of the outstanding shares of Common Stock on a fully-diluted basis, which includes 14,866,667 shares of Common Stock issuable upon the conversion of 1,486,666.7 Preferred Shares.
As of September 17, 2012, following the consummation of the redemption as described in Item 4, OEP and each of the other Reporting Persons may be deemed to own beneficially 11,892,560 shares of Common Stock, representing approximately 42.7% of the outstanding Common Stock on a fully-diluted basis.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
Escrow Agreement
On May 16, 2011, OEP, the Issuer, and the Hong Kong branch of JPMorgan Chase Bank, N.A. (the “
Escrow Agent
”) entered into the Escrow Agreement pursuant to which an escrow account (the “
Escrow Account
”) was created by the Escrow Agent.
Escrow Funds Loan Agreement
On March 2, 2012, OEP and the Issuer entered into the Escrow Funds Loan Agreement pursuant to which the Issuer borrowed the Renminbi equivalent of US$2,000,000 (the “
Loan
”) in order for the Issuer to pay accrued expenses relating to certain accounting, legal and consulting services rendered to it by third party service providers.
Guangzhou Escrow Agreement
On January 31, 2012, OEP, Guangzhou Konzern Medicine Co., Ltd. and JPMorgan Chase Bank (China) Company Limited acting through its Guangzhou Branch (the “
Guangzhou Escrow Agent
”), entered into the Escrow Agreement (the “
Guangzhou Escrow Agreement
”) pursuant to which an escrow account (the “
Guangzhou Escrow Account
”) was created by the Guangzhou Escrow Agent.
Item 7. Material to Be Filed as Exhibits
|
Exhibit 1
|
Escrow Agreement, dated as of May 16, 2011 among China Medicine Corporation, OEP CHME Holdings, LLC and the Hong Kong branch of JPMorgan Chase Bank, N.A.
|
|
Exhibit 2
|
Escrow Funds Loan Agreement, dated as of March 2, 2012 between OEP CHME Holdings, LLC and China Medicine Corporation.
|
|
Exhibit 3
|
Escrow Agreement, dated as of January 31, 2012 among Guangzhou Konzern Medicine Co., Ltd., OEP CHME Holdings, LLC and JPMorgan Chase Bank (China) Company Limited Guangzhou Branch.
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
OEP CHME HOLDINGS, LLC
|
|
|
|
|
|
By:
|
One Equity Partners III, L.P.,
|
|
|
|
as Managing Member
|
|
|
|
|
|
By:
|
OEP General Partner III, L.P,
|
|
|
|
as general partner
|
|
|
|
|
|
By:
|
OEP Parent LLC,
|
|
|
|
as general partner
|
|
|
|
|
|
By:
|
/s/ Richard W. Smith
|
|
|
|
Name:
|
Richard W. Smith
|
|
|
Title:
|
Managing Director
|
|
|
|
|
|
ONE EQUITY PARTNERS III, L.P.
|
|
|
|
|
|
By:
|
OEP General Partner III, L.P,
|
|
|
|
as general partner
|
|
|
|
|
|
By:
|
OEP Parent LLC,
|
|
|
|
as general partner
|
|
|
|
|
|
By:
|
/s/ Richard W. Smith
|
|
|
|
Name:
|
Richard W. Smith
|
|
|
Title:
|
Managing Director
|
|
|
|
|
|
OEP GENERAL PARTNER III, L.P.
|
|
|
|
|
|
By:
|
OEP Parent LLC,
|
|
|
|
as general partner
|
|
|
|
|
|
By:
|
/s/ Richard W. Smith
|
|
|
|
Name:
|
Richard W. Smith
|
|
|
Title:
|
Managing Director
|
|
|
|
|
|
OEP PARENT LLC
|
|
|
|
|
|
|
|
|
By:
|
/s/ Richard W. Smith
|
|
|
|
Name:
|
Richard W. Smith
|
|
|
Title:
|
Managing Director
|
|
|
|
|
|
|
|
Date September 17, 2012
|
|
|
|
|
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
Schedule A is hereby amended and supplemented as follows:
DIRECTORS AND EXECUTIVE OFFICERS OF OEP PARENT LLC
The names of the directors and the names and titles of the executive officers of OEP Parent LLC and their present principal occupations and residence or business addresses are set forth below. Each position set forth opposite an individual’s name refers to OEP Parent LLC and each individual is a United States citizen.
|
Name
|
|
Position
|
|
Address
|
|
Richard M. Cashin
|
|
President and Manager
|
|
320 Park Avenue, NY, NY 10022
|
|
Christian P. Ahrens
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Raphael L. de Balmann
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Gregory A. Belinfanti
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Henry H. Briance
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
James B. Cherry
|
|
Managing Director
|
|
21 South Clark Street, Chicago IL 60603-2003
|
|
Andrew G. Dunn
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Colin M. Farmer
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
David Han
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Joseph P. Huffsmith
|
|
Managing Director
|
|
10 South Dearborn, Chicago Illinois 60603-2003
|
|
Thomas J. Kichler
|
|
Managing Director
|
|
10 South Dearborn, Chicago Illinois 60603-2003
|
|
James W. Koven
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Joseph G. Michels
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Jacques Nasser
|
|
Managing Director
|
|
1400 East Newport Center Drive, Deerfield Beach, FL 33442-7737
|
|
David Robakidze
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Charles W. Scharf
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
Richard W. Smith
|
|
Managing Director and Manager
|
|
320 Park Avenue, NY, NY 10022
|
|
David A. Walsh
|
|
Managing Director
|
|
320 Park Avenue, NY, NY 10022
|
|
William H. Wangerin
|
|
Managing Director
|
|
21 South Clark Street, Chicago IL 60603-2003
|
|
Matthew P. Hughes
|
|
Vice President
|
|
320 Park Avenue, NY, NY 10022
|
|
Ravish V. Patwardhan
|
|
Vice President
|
|
320 Park Avenue, NY, NY 10022
|
|
Kathryn L. Bryan
|
|
Chief Operating Officer & Chief Financial Officer
|
|
320 Park Avenue, NY, NY 10022
|
|
Judah A. Shechter
|
|
General Counsel & Secretary
|
|
270 Park Avenue, NY, NY 10017
|
|
Si-Yeon Kim
|
|
Chief Compliance Officer
|
|
320 Park Avenue, NY, NY 10022
|
|
Colleen A. Greenrod
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Jessica R. Marion
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Asha T. Eapen
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Dora M. Stojka
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Elizabeth De Guzman
|
|
Vice President & Assistant Secretary
|
|
270 Park Avenue, NY, NY 10017
|
|
Jay Mandelbaum
|
|
Manager
|
|
270 Park Avenue, NY, NY 10017
|
|
Doublas B. Petno
|
|
Manager
|
|
270 Park Avenue, NY, NY 10017
|
|
Robert Rubin
|
|
Manager
|
|
320 Park Avenue, NY, NY 10022
|
|
Matthew W. James
|
|
Manager
|
|
270 Park Avenue, NY, NY 10017
|
|
Barry L. Zubrow
|
|
Manager
|
|
270 Park Avenue, NY, NY 10017
|
DIRECTORS AND EXECUTIVE OFFICERS OF OEP HOLDING CORPORATION
The names of the directors and the names and titles of the executive officers of OEP Holding Corporation and their present principal occupations and residence or business addresses are set forth below. Each position set forth opposite an individual’s name refers to OEP Holding Corporation and each individual is a United States citizen.
|
Name
|
|
Position
|
|
Address
|
|
Richard M. Cashin
|
|
Director and President
|
|
320 Park Avenue, New York, NY 10022
|
|
Christian P. Ahrens
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Gregory A. Belinfanti
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Henry H. Briance
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
James B. Cherry
|
|
Managing Director
|
|
21 South Clark Street, Chicago, IL 60603-
2003
|
|
Raphael de Balmann
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Andrew G. Dunn
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Colin M. Farmer
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
David Han
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Joseph Huffsmith
|
|
Managing Director
|
|
10 South Dearborn, Chicago Illinois 60603-2003
|
|
Thomas J. Kichler
|
|
Managing Director
|
|
10 South Dearborn, Chicago Illinois 60603-2003
|
|
James W. Koven
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Joseph G. Michels
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Jac Nasser
|
|
Managing Director
|
|
1400 East Newport Center Drive, Deerfield Beach, FL, 33442-7737
|
|
David Robakidze
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Charles W. Scharf
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
Richard W. Smith
|
|
Managing Director and Director
|
|
320 Park Avenue, New York, NY 10022
|
|
David A. Walsh
|
|
Managing Director
|
|
320 Park Avenue, New York, NY 10022
|
|
William H. Wangerin
|
|
Managing Director
|
|
21 South Clark Street, Chicago, IL 60603-2003
|
|
Matthew P. Hughes
|
|
Vice President
|
|
320 Park Avenue, New York, NY 10022
|
|
Ravish V. Patwardhan
|
|
Vice President
|
|
320 Park Avenue, New York, NY 10022
|
|
Kathryn L. Bryan
|
|
Chief Operating Officer & Chief
Financial Officer
|
|
320 Park Avenue, New York, NY 10022
|
|
Judah A. Shechter
|
|
General Counsel & Secretary
|
|
320 Park Avenue, New York, NY 10022
|
|
Si-Yeon Kim
|
|
Chief Compliance Officer
|
|
320 Park Avenue, New York, NY 10022
|
|
Elizabeth De Guzman
|
|
Vice President & Assistant Secretary
|
|
270 Park Avenue, New York, NY 10017
|
|
Asha T. Eapen
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Colleen A. Greenrod
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Jessica R. Marion
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Dora M. Stojka
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
DIRECTORS AND EXECUTIVE OFFICERS OF JPMORGAN CAPITAL CORPORATION
The names of the directors and the names and titles of the executive officers of JPMorgan Capital Corporation and their present principal occupations and residence or business addresses are set forth below. Each position set forth opposite an individual’s name refers to JPMorgan Capital Corporation and each individual is a United States citizen.
|
Name
|
|
Position
|
|
Address
|
|
Ellen J. Manola
|
|
Director
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Francisco J. Pereiro
|
|
Director
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Peter G. Weiland
|
|
Director
|
|
270 Park Avenue, New York, NY 10017
|
|
Scott Abramson
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Richard D. Archer
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Christine N. Bannerman
|
|
Vice President & Assistant Secretary
|
|
4 Chase Metrotech, Brooklyn, NY 11245
|
|
Daniel A. Balazs
|
|
Associate
|
|
10 South Dearborn, Chicago, IL, 60603-2300
|
|
Geoffrey P. Bratton
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Michael S. Bryant
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Browne, Brigid
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Mit C. Buchanan
|
|
Managing Director
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
William R. Crissy
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Cynthia Cain
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Ana E. Conforti
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Richard S. Crowley
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Victoria B. Dal Santo
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Sheila K Delaney
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Anand Dandapani
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Jason T. Dinneen
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Hellen Doo
|
|
Vice President & Asst Secretary
|
|
245 Park Avenue, New York, NY 10167-0001
|
|
Antonina Doria
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Mary K. Duff
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
James A. Durham
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Sean M. Dwyer
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
John M. Eber
|
|
Managing Director
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
James M. Eligator
|
|
Managing Director
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Mary Eymard
|
|
Vice President
|
|
451 Florida Street, Baton Rouge, LA 70801-1700
|
|
Jean Fanning
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Frieda B. Feiger
|
|
Associate
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Linda L. Fernandez
|
|
Associate
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
James A. Fox
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Emily M. Garrett
|
|
Vice President
|
|
383 Madison Avenue, New York, NY 10179
|
|
Brett A. Geiger
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Heather Glover
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Brian R. Gnolfo
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Darlene T. Golly
|
|
Associate
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Amber Haley
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Patricia T. Habicht
|
|
Assistant Secretary
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Eric J. Hamm
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Elizabeth M. Hayes
|
|
Associate
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Michael D. Heine
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Yale C. Henderson
|
|
Managing Director
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Jeffrey L. Hinds
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Philipp A. Hirche
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Anthony J. Horan
|
|
Senior Vice President & Assistant Secretary
|
|
277 Park Avenue, New York, NY 10172
|
|
Rondella Hunt
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
John T. Hunter
|
|
Vice President
|
|
10 South Dearborn, Chicago IL 60603-2203
|
|
Steven N. Ignelzi
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Michelle L. Jones
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Suzanne M. Jones
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Min Yun Kim
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Jan I. Krueger
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
William P. Kusack Jr
|
|
Managing Director
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Elisa A. Lass
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Lennox Leighton
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Mark Lenhardt
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Melvina E. Lloyd
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Kurt Lundgren
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Ellen J. Manola
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Ellen J. Manola
|
|
Treasurer
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Kin, Ryan
|
|
Vice President
|
|
10 South Dearborn Chicago, IL 60603-2203
|
|
Douglas, S. Lloyd
|
|
Executive Director (Officer)
|
|
10 South Dearborn Chicago, IL 60603-2203
|
|
Marie Y. Martinez
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Mark J. McCann
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Colleen A. Meade
|
|
Executive Director (Officer) Secretary
|
|
4 Chase Metrotech Center, Brooklyn, NY 11245-0001
|
|
Allison Metzger
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
D. C. Robinson
|
|
Executive Director
|
|
10 South Dearborn Chicago, IL 60603-2203
|
|
Deanna C. Mueller
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Patrick J. Nash
|
|
Managing Director
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Naveed Nabavi
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Roxanne C. Nicolas
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Timothy P. O’Keefe
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Susan M. Ochoa
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Gina I. Orlando
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Jon W. Pagac
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Melanie A. Pagliari
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Susan Parsons
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Anne F. Pax
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
William C. Pelletier
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Bonnie L. Percy-Hill
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Francisco J. Pereiro
|
|
Chairman
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Francisco J. Pereiro
|
|
President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Brian Polt
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Jeremy S. Reinhard
|
|
Vice President
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Paulius Remeza
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
D. C. Robinson
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Mary F. Sackley
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
John P. Scothorn
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Shahani, Hasmita
|
|
Associate
|
|
10 South Dearborn Chicago, IL, 60603-2203
|
|
Socheat V. Som
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Rubiao Song
|
|
Executive Director (Officer)
|
|
383 Madison Avenue, New York, NY 10179
|
|
Joel P. Spenadel
|
|
Executive Director (Officer)
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Jeffrey S. Steenwyk
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Theodora Stojka
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Aloysius T. Stonitsch
|
|
Managing Director
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
David R. Stoppel
|
|
Associate
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Patricia L. Striegel
|
|
Associate
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Galina Tam
|
|
Associate
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Bradley R. Tieche
|
|
Associate
|
|
10 South Dearborn, Chicago, IL 60603-2203
|
|
Eric T. White
|
|
Executive Director (Officer)
|
|
10 South Dearborn Chicago, IL, 60603-2203
|
|
Damian Warshall
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Krystal Zec
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
|
Jon D. Zywiciel
|
|
Vice President
|
|
10 South Dearborn, Chicago IL, 60603-2203
|
DIRECTORS AND EXECUTIVE OFFICERS OF BANC ONE FINANCIAL LLC
The names and titles of the executive officers of Banc One Financial LLC and their present principal occupations and residence or business addresses are set forth below. Each position set forth opposite an individual’s name refers Banc One Financial LLC and each individual is a United States citizen.
|
Name
|
|
Position
|
|
Address
|
|
Michael J. Cavanagh
|
|
Director and Chairman of the Board
|
|
270 Park Avenue, New York, NY 10017
|
|
Christine N. Bannerman
|
|
Assistant Secretary
|
|
270 Park Avenue, New York, NY 10017
|
|
Francis J. Drozek
|
|
Assistant Treasurer
|
|
270 Park Avenue, New York, NY 10017
|
|
Lisa J. Fitzgerald
|
|
Managing Director
|
|
270 Park Avenue, New York, NY 10017
|
|
James A. Fox
|
|
Executive Director (Officer)
|
|
270 Park Avenue, New York, NY 10017
|
|
Jeffrey L. Hinds
|
|
Executive Director (Officer)
|
|
270 Park Avenue, New York, NY 10017
|
|
John J. Hyland
|
|
Vice president & Treasurer
|
|
270 Park Avenue, New York, NY 10017
|
|
Eva Loeffler
|
|
Assistant Secretary
|
|
270 Park Avenue, New York, NY 10017
|
|
Patrick J. Nash
|
|
Managing Director
|
|
270 Park Avenue New York, NY 10017
|
|
Carin S. Reddish
|
|
Assistant Secretary
|
|
270 Park Avenue, New York, NY 10017
|
|
Aloysius Stonitsch
|
|
Managing Director
|
|
270 Park Avenue, New York, NY 10017
|
DIRECTORS AND EXECUTIVE OFFICERS OF JPMORGAN CHASE & CO.
The names and titles of the directors and executive officers of JPMorgan Chase & Co. and their present principal occupations and residence or business addresses are set forth below. Each occupation set forth opposite an individual’s name refers to JPMorgan Chase & Co. unless otherwise noted and each individual is a United States citizen.
|
Name
|
|
Position
|
|
Address
|
|
James Dimon
|
|
President, Chief Executive Officer and Chairman of the Board of Directors
|
|
270 Park Avenue, New York, NY 10017
|
|
Frank Bisignano
|
|
Chief Administrative Officer
|
|
270 Park Avenue, New York, NY 10017
|
|
Douglas L. Braunstein
|
|
Chief Financial Officer
|
|
270 Park Avenue, New York, NY 10017
|
|
Michael J. Cavanagh
|
|
Chief Executive Officer of Treasury & Securities Services
|
|
270 Park Avenue, New York, NY 10017
|
|
Stephen M. Cutler
|
|
General Counsel
|
|
270 Park Avenue, New York, NY 10017
|
|
John L. Donnelly
|
|
Director of Human Resources
|
|
270 Park Avenue, New York, NY 10017
|
|
Mary E. Erdoes
|
|
Chief Executive Officer of Asset Management
|
|
270 Park Avenue, New York, NY 10017
|
|
John J. Hogan
|
|
Chief Risk Officer
|
|
270 Park Avenue, New York, NY 10017
|
|
Samuel Todd Maclin
|
|
Chief Executive Officer of Consumer and Business Banking
|
|
270 Park Avenue, New York, NY 10017
|
|
Douglas B. Petno
|
|
Chief Executive Officer of Commercial Banking
|
|
270 Park Avenue, New York, NY 10017
|
|
Gordon A. Smith
|
|
Chief Executive Officer Card Services
|
|
270 Park Avenue, New York, NY 10017
|
|
James E. Staley
|
|
Chief Executive Officer of Investment Bank Management
|
|
270 Park Avenue, New York, NY 10017
|
|
Matthew E. Zames
|
|
Chief Investment Officer
|
|
270 Park Avenue, New York, NY 10017
|
|
Barry L. Zubrow
|
|
Head of Corporate Regulatory Affairs
|
|
270 Park Avenue, New York, NY 10017
|
|
James A. Bell
|
|
Director; also, Retired Executive Vice President of The Boeing Company
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
Crandall C. Bowles
|
|
Director; also, Chairman of Spring Industries, Inc.
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
Stephen B. Burke
|
|
Director; also, Chief Executive Officer of NBC Universal, LLC and Executive Vice President of Comcast Cable Communications Inc.
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
David M. Cote
|
|
Director; also, Chairman and Chief Executive Officer of Honeywell International Inc.
|
|
c/o JPMorgan Chase & Co. , 270 Park Avenue, New York, NY 10017
|
|
James S. Crown
|
|
Director; also, President of Henry Crown and Company
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
Timothy P. Flynn
|
|
Director; also, Retired Chairman of KPMG International
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
Ellen V. Futter
|
|
Director; also, President and Trustee of American Museum of Natural History
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
Laban P. Jackson Jr.
|
|
Director; also, Chairman and Chief Executive Officer of Clear Creek Properties
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
Lee R. Raymond
|
|
Director; also, Retired Chairman and Chief Executive Officer of Exxon Mobil Corporation
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
|
William C. Weldon
|
|
Director; also, Chairman and Chief Executive Officer of Johnson & Johnson
|
|
c/o JPMorgan Chase & Co., 270 Park Avenue, New York, NY 10017
|
China Medicine (CE) (USOTC:CHME)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
China Medicine (CE) (USOTC:CHME)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
